During the past two decades, the medical biotechnology industry has successfully introduced more than 160 drugs and vaccines to the marketplace. A large proportion of these drugs are protein-based therapeutics. This is the era of protein based drugs writers have chosen this subject, which is quite useful not only for academic but also for the related industry. Keeping above in mind, the book discusses not only about the technical matters like proteins, importance of proteins, some important protein based drugs and their production process, synthetic peptides, quality control and characterization, delivery systems and formulation development but also commercialization aspects like- World scenario, Regulatory aspects, Therapeutic innovation, intellectual property rights and Guide to new entrepreneurs.
ABOUT THE AUTHOR Chiranjib Chakraborty
Dr. Chiranjib Chakraborty, R&D Manager in Biotechnology, Glenmark Laboratories, (Pharmaceutical Company is well known for his notable contribution of different technology development in biological field. A Ph.D. from Vidyasagar University (West Bengal) and Marine Aquarium and Research Center (ZSI) did his post-doctoral research in USA. He is a recipient of several medals and awards including Snehalata Banerjee Gold medal from the Academy of Environmental Biology for the publication of best paper in 1998. Dr. Chakraborty started his professional career as Lecturer in the department of Industrial Fish and Fishery, Burdwan Raj College, West Bengal and also worked as Research Scientist in Biotechnology at Macleod Pharmaceuticals, Mumbai. He visited several institutes like IIT. Kharagpur; IIT, New Delhi; All Indian Institute of Medical Science, New Delhi; Department of Biotechnology; Jadavpur University, Calcutta; ERI ,Chennai and Lee and Nee Software export Ltd, Calcutta for exchange of his scientific ideas. He has a good number of original research papers, review articles and four books published both within and outside India. His unstinted efforts in research have enriched seed production biotechnology of prawns; production technology development & stability of recombinant pharmaceutical proteins and diagnostics technology development through computational biology like protein microarray.
ABOUT THE AUTHOR Rajesh Jhingan
Rajesh Jhingan is Vice-President of Glenmark Laboratories, Mumbai. Previously he was International Business Head in Kee Biogenetics & Cimmco Birla Limited.
There are no reviews yet.